The current status of interferon-alpha treatment in advanced renal cancer (Q34249614)

31 July 2017

1 reference

title

The current status of interferon-alpha treatment in advanced renal cancer (English)

1 reference

31 July 2017

Stebbing J

1 reference

31 July 2017

Gore M

series ordinal

1 reference

31 July 2017

publication date

1 May 2001

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

1 reference

31 July 2017

page(s)

599-601

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2001.02140.X

31 July 2017

1 reference

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2001.02140.X

Adjuvant interferon-alpha in malignant melanoma: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2001.02140.X

The impact of interleukin-2 on survival in renal cancer: a multivariate analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2001.02140.X

Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2001.02140.X

Interaction of retinoic acid and interferon in renal cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2001.02140.X

Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2001.02140.X

Recombinant leukocyte interferon alpha-2a and medroxyprogesterone in advanced renal cell carcinoma. A randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2001.02140.X

Interferon alfa and vinblastine versus medroxyprogesterone acetate in the treatment of metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2001.02140.X

Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1464-410X.2001.02140.X

Immunotherapy for advanced renal cell cancer.

21 January 2018

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD001425

Identifiers

DOI

10.1046/J.1464-410X.2001.02140.X

1 reference

31 July 2017

1 reference